{"transactions":[{"id":67978,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-04-04T17:16:25.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":177,"price":162.11,"value":28693.47,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":28474,"derivative":{"exercise_price":162.11,"underlying":"Common Stock","underlying_shares":177},"source":{"system":"sec-edgar","filing":"0001179110-22-002546","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911022002546/edgar.xml","form_type":"4"}},{"id":73620,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-01-04T17:03:37.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":212,"price":135.4,"value":28704.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":28024,"derivative":{"exercise_price":135.4,"underlying":"Common Stock","underlying_shares":212},"source":{"system":"sec-edgar","filing":"0001179110-22-000120","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911022000120/edgar.xml","form_type":"4"}},{"id":79732,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-10-04T17:04:39.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":266,"price":107.87,"value":28693.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":27506,"derivative":{"exercise_price":107.87,"underlying":"Common Stock","underlying_shares":266},"source":{"system":"sec-edgar","filing":"0001179110-21-009161","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911021009161/edgar.xml","form_type":"4"}},{"id":84914,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-07-02T09:09:20.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":284,"price":112.67,"value":31998.28,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The cash equivalent of 1,748 stock equivalent units in the Abbott account was paid to the director upon his retirement from Abbott's board on May 1, 2021. The stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The cash equivalent of 1,748 stock equivalent units in the Abbott account was paid to the director upon his retirement from Abbott's board on May 1, 2021. The stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":26944,"derivative":{"exercise_price":112.67,"underlying":"Common Stock","underlying_shares":284},"source":{"system":"sec-edgar","filing":"0001179110-21-007283","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911021007283/edgar.xml","form_type":"4"}},{"id":87968,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2021-05-11T17:06:15.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":1681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":26683,"source":{"system":"sec-edgar","filing":"0001179110-21-005202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911021005202/edgar.xml","form_type":"4"}},{"id":90176,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-04-01T16:43:33.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":311,"price":108.22,"value":33656.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":28094,"derivative":{"exercise_price":108.22,"underlying":"Common Stock","underlying_shares":311},"source":{"system":"sec-edgar","filing":"0001179110-21-003956","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911021003956/edgar.xml","form_type":"4"}},{"id":95955,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-01-05T17:01:49.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":314,"price":107.15,"value":33645.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":27440,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":314},"source":{"system":"sec-edgar","filing":"0001179110-21-000195","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911021000195/edgar.xml","form_type":"4"}},{"id":100589,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-10-02T16:52:36.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":385,"price":87.59,"value":33722.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":26908,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":385},"source":{"system":"sec-edgar","filing":"0001179110-20-010195","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911020010195/edgar.xml","form_type":"4"}},{"id":103544,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-07-02T09:28:20.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":335,"price":98.18,"value":32890.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":26288,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":335},"source":{"system":"sec-edgar","filing":"0001179110-20-007839","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911020007839/edgar.xml","form_type":"4"}},{"id":104910,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2020-05-12T17:00:34.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":2333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":25002,"source":{"system":"sec-edgar","filing":"0001179110-20-005781","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911020005781/edgar.xml","form_type":"4"}},{"id":3164820,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-04T21:27:12.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":222.157,"price":151.92,"value":33750.09144,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":59810.252,"source":{"system":"sec-edgar","filing":"0001127602-20-015239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760220015239/form4.xml","form_type":"4"}},{"id":391444,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-04-28T21:23:08.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":9671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":9671,"derivative":{"exercise_price":93.68,"exercise_date":"2020-04-24","expiration_date":"2030-04-23","underlying":"Common shares","underlying_shares":9671},"source":{"system":"sec-edgar","filing":"0001179110-20-005182","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005182/edgar.xml","form_type":"4"}},{"id":391443,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2020-04-28T21:23:08.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":1974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":30127,"source":{"system":"sec-edgar","filing":"0001179110-20-005182","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005182/edgar.xml","form_type":"4"}},{"id":392169,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2020-04-03T22:16:58.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":108.14,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":22925.88,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":108.14},"source":{"system":"sec-edgar","filing":"0001225208-20-006075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520820006075/doc4.xml","form_type":"4"}},{"id":105744,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-04-02T17:02:32.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":426,"price":76.19,"value":32456.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":25428,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":426},"source":{"system":"sec-edgar","filing":"0001179110-20-004517","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911020004517/edgar.xml","form_type":"4"}},{"id":3296100,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-03T18:41:11.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":207.68,"price":162.51,"value":33750.0768,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":58999.029,"source":{"system":"sec-edgar","filing":"0001127602-20-003028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760220003028/form4.xml","form_type":"4"}},{"id":397072,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2020-01-06T23:23:07.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":151.27,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":22636.77,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":151.27},"source":{"system":"sec-edgar","filing":"0001225208-20-000567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520820000567/doc4.xml","form_type":"4"}},{"id":109419,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-01-03T12:40:55.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":367,"price":88.54,"value":32494.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":24692,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":367},"source":{"system":"sec-edgar","filing":"0001179110-20-000104","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911020000104/edgar.xml","form_type":"4"}},{"id":3385927,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-10-30T16:52:30.000Z","date":"2019-10-29","kind":"grant","acquired":true,"shares":199.634,"price":169.06,"value":33750.12404,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":58293.833,"source":{"system":"sec-edgar","filing":"0001127602-19-031228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760219031228/form4.xml","form_type":"4"}},{"id":399808,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2019-10-03T21:02:25.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":132.02,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":22354.53,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":132.02},"source":{"system":"sec-edgar","filing":"0001225208-19-013169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520819013169/doc4.xml","form_type":"4"}},{"id":112351,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-10-01T17:50:42.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":429,"price":75.72,"value":32483.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":24035,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":429},"source":{"system":"sec-edgar","filing":"0001104659-19-052308","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000110465919052308/a4.xml","form_type":"4"}},{"id":3452843,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-07-31T22:12:27.000Z","date":"2019-07-30","kind":"grant","acquired":true,"shares":190.937,"price":176.76,"value":33750.02412,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":57600.681,"source":{"system":"sec-edgar","filing":"0001127602-19-025564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760219025564/form4.xml","form_type":"4"}},{"id":401609,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2019-07-03T20:27:01.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":139.17,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":22097.07,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":139.17},"source":{"system":"sec-edgar","filing":"0001225208-19-010046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520819010046/doc4.xml","form_type":"4"}},{"id":115540,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-07-02T13:13:25.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":446,"price":72.72,"value":32433.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":23211,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":446},"source":{"system":"sec-edgar","filing":"0001179110-19-008307","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911019008307/edgar.xml","form_type":"4"}},{"id":3525269,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-16T13:06:56.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":976.619,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":56924.414,"source":{"system":"sec-edgar","filing":"0001127602-19-018624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760219018624/form4.xml","form_type":"4"}},{"id":116868,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2019-05-07T16:53:33.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":2419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":22669,"source":{"system":"sec-edgar","filing":"0001179110-19-005670","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911019005670/edgar.xml","form_type":"4"}},{"id":3543666,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-02T16:12:16.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":177.436,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":55947.572,"source":{"system":"sec-edgar","filing":"0001127602-19-016865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760219016865/form4.xml","form_type":"4"}},{"id":403750,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-04-30T21:16:34.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":11606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":11606,"derivative":{"exercise_price":78.06,"exercise_date":"2019-04-26","expiration_date":"2029-04-25","underlying":"Common shares","underlying_shares":11606},"source":{"system":"sec-edgar","filing":"0001179110-19-005305","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019005305/edgar.xml","form_type":"4"}},{"id":403749,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2019-04-30T21:16:34.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":2241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":28153,"source":{"system":"sec-edgar","filing":"0001179110-19-005305","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019005305/edgar.xml","form_type":"4"}},{"id":404369,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2019-04-03T20:57:19.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":144.62,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":21831.09,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":144.62},"source":{"system":"sec-edgar","filing":"0001225208-19-006358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520819006358/doc4.xml","form_type":"4"}},{"id":117890,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-04-02T17:05:45.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":403,"price":80.59,"value":32477.77,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":22459,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":403},"source":{"system":"sec-edgar","filing":"0001179110-19-004526","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911019004526/edgar.xml","form_type":"4"}},{"id":409175,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2019-01-04T21:25:53.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":141.14,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":21586.36,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":141.14},"source":{"system":"sec-edgar","filing":"0001225208-19-000591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520819000591/doc4.xml","form_type":"4"}},{"id":121386,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-01-03T16:51:25.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":352,"price":92.19,"value":32450.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":21768,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":352},"source":{"system":"sec-edgar","filing":"0001179110-19-000235","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911019000235/edgar.xml","form_type":"4"}},{"id":3766002,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-14T17:05:29.000Z","date":"2018-11-13","kind":"grant","acquired":true,"shares":184,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":55009,"source":{"system":"sec-edgar","filing":"0001127602-18-032974","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760218032974/form4.xml","form_type":"4"}},{"id":411476,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-10-03T22:44:09.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":118.7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":21334.5,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":118.7},"source":{"system":"sec-edgar","filing":"0001225208-18-014370","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520818014370/doc4.xml","form_type":"4"}},{"id":124051,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-10-02T14:06:46.000Z","date":"2018-09-30","kind":"grant","acquired":true,"shares":343,"price":94.58,"value":32440.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":21190,"derivative":{"underlying":"Common Stock","underlying_shares":343},"source":{"system":"sec-edgar","filing":"0001179110-18-011829","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911018011829/edgar.xml","form_type":"4"}},{"id":3844311,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-15T15:11:24.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":197,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":54461,"source":{"system":"sec-edgar","filing":"0001127602-18-025408","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760218025408/form4.xml","form_type":"4"}},{"id":413618,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-07-05T20:45:15.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":135.21,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":21111.83,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":135.21},"source":{"system":"sec-edgar","filing":"0001225208-18-011468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520818011468/doc4.xml","form_type":"4"}},{"id":127225,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-07-02T16:40:02.000Z","date":"2018-06-30","kind":"grant","acquired":true,"shares":341,"price":92.65,"value":31593.65,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":20643,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":341},"source":{"system":"sec-edgar","filing":"0001179110-18-009207","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911018009207/edgar.xml","form_type":"4"}},{"id":3940285,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-10T20:04:19.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":951,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":53592,"source":{"system":"sec-edgar","filing":"0001127602-18-016975","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760218016975/form4.xml","form_type":"4"}},{"id":3940284,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-10T20:04:19.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":5,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reported transaction reflects an increase in the Annual Cash Retainer portion of the non-employee director compensation, effective January 1, 2018, that was approved by the Board of Directors on May 8, 2018."}],"balance_after":52641,"source":{"system":"sec-edgar","filing":"0001127602-18-016975","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760218016975/form4.xml","form_type":"4"}},{"id":129144,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2018-05-07T20:27:13.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":1899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":20250,"source":{"system":"sec-edgar","filing":"0001179110-18-006407","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911018006407/edgar.xml","form_type":"4"}},{"id":415414,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-05-01T23:10:27.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":15247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":15247,"derivative":{"exercise_price":59.42,"exercise_date":"2018-04-27","expiration_date":"2028-04-26","underlying":"Common shares","underlying_shares":15247},"source":{"system":"sec-edgar","filing":"0001179110-18-006025","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018006025/edgar.xml","form_type":"4"}},{"id":415413,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2018-05-01T23:10:27.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":25912,"source":{"system":"sec-edgar","filing":"0001179110-18-006025","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018006025/edgar.xml","form_type":"4"}},{"id":416024,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-04-04T20:42:50.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":139.08,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":20876.43,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":139.08},"source":{"system":"sec-edgar","filing":"0001225208-18-007368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520818007368/doc4.xml","form_type":"4"}},{"id":130265,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-04-02T13:54:54.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":330,"price":94.65,"value":31234.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":20115,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":330},"source":{"system":"sec-edgar","filing":"0001179110-18-005009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911018005009/edgar.xml","form_type":"4"}},{"id":4075356,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-02-06T21:58:06.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":159,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":52636,"source":{"system":"sec-edgar","filing":"0001127602-18-004328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760218004328/form4.xml","form_type":"4"}},{"id":420647,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-01-04T22:48:59.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":151.93,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":20633.79,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":151.93},"source":{"system":"sec-edgar","filing":"0001225208-18-000717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520818000717/doc4.xml","form_type":"4"}},{"id":134052,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2018-01-03T17:06:11.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":323,"price":96.71,"value":31237.33,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":19664,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":323},"source":{"system":"sec-edgar","filing":"0001179110-18-000330","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911018000330/edgar.xml","form_type":"4"}},{"id":4161571,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-11-16T15:27:27.000Z","date":"2017-11-14","kind":"grant","acquired":true,"shares":179,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":52209,"source":{"system":"sec-edgar","filing":"0001127602-17-032294","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760217032294/form4.xml","form_type":"4"}},{"id":423040,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-10-04T21:45:23.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":176.64,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":20376.51,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":176.64},"source":{"system":"sec-edgar","filing":"0001225208-17-015952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520817015952/doc4.xml","form_type":"4"}},{"id":136682,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-10-03T16:32:36.000Z","date":"2017-09-30","kind":"grant","acquired":true,"shares":351,"price":88.86,"value":31189.86,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":19147,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":351},"source":{"system":"sec-edgar","filing":"0001179110-17-012955","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911017012955/edgar.xml","form_type":"4"}},{"id":423921,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2017-08-22T21:04:02.000Z","date":"2017-08-14","kind":"purchase","acquired":true,"shares":1185,"price":48.9556,"value":58012.386,"ownership":{"direct":true},"balance_after":22967,"source":{"system":"sec-edgar","filing":"0001179110-17-011737","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017011737/edgar.xml","form_type":"4"}},{"id":4233397,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-16T21:59:15.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":180,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"balance_after":51735,"source":{"system":"sec-edgar","filing":"0001127602-17-025833","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760217025833/form4.xml","form_type":"4"}},{"id":424972,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-07-06T20:34:42.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":226.59,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":20081.47,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":226.59},"source":{"system":"sec-edgar","filing":"0001225208-17-012349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520817012349/doc4.xml","form_type":"4"}},{"id":139165,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-07-05T11:39:46.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":430,"price":72.51,"value":31179.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":18688,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":430},"source":{"system":"sec-edgar","filing":"0001179110-17-009955","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911017009955/edgar.xml","form_type":"4"}},{"id":4327702,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-10T21:28:22.000Z","date":"2017-05-09","kind":"grant","acquired":true,"shares":1058,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors."}],"balance_after":51254,"source":{"system":"sec-edgar","filing":"0001127602-17-017588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760217017588/form4.xml","form_type":"4"}},{"id":4327701,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-10T21:28:22.000Z","date":"2017-05-09","kind":"grant","acquired":true,"shares":14,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reported transaction reflects an increase in the Annual Cash Retainer portion of the non-employee director compensation, effective January 1, 2017, that was approved by the Board of Directors on May 9, 2017."}],"balance_after":50196,"source":{"system":"sec-edgar","filing":"0001127602-17-017588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760217017588/form4.xml","form_type":"4"}},{"id":140815,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2017-05-09T17:21:42.000Z","date":"2017-05-05","kind":"grant","acquired":true,"shares":2770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":18351,"source":{"system":"sec-edgar","filing":"0001179110-17-006927","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911017006927/edgar.xml","form_type":"4"}},{"id":426898,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2017-05-02T21:09:25.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":19890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":19890,"derivative":{"exercise_price":43.64,"exercise_date":"2017-04-28","expiration_date":"2027-04-27","underlying":"Common shares","underlying_shares":19890},"source":{"system":"sec-edgar","filing":"0001179110-17-006406","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017006406/edgar.xml","form_type":"4"}},{"id":426897,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2017-05-02T21:09:25.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":3437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":21782,"source":{"system":"sec-edgar","filing":"0001179110-17-006406","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017006406/edgar.xml","form_type":"4"}},{"id":427508,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-04-05T21:28:52.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":254.79,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":19707.34,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":254.79},"source":{"system":"sec-edgar","filing":"0001225208-17-007687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520817007687/doc4.xml","form_type":"4"}},{"id":141598,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-04-04T17:30:51.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":479,"price":65.16,"value":31211.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":18083,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":479},"source":{"system":"sec-edgar","filing":"0001179110-17-005605","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911017005605/edgar.xml","form_type":"4"}},{"id":4463128,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-02-08T17:56:16.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":196,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non- Employee Directors."}],"balance_after":49855,"source":{"system":"sec-edgar","filing":"0001127602-17-004519","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760217004519/form4.xml","form_type":"4"}},{"id":431973,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-01-05T21:51:45.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":288.14,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":19302.37,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":288.14},"source":{"system":"sec-edgar","filing":"0001225208-17-000750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520817000750/doc4.xml","form_type":"4"}},{"id":432142,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-01-04T22:05:44.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":859,"price":38.41,"value":32994.19,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":20113,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":859},"source":{"system":"sec-edgar","filing":"0001179110-17-000268","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017000268/edgar.xml","form_type":"4"}},{"id":145303,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2017-01-04T17:31:50.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":499,"price":62.62,"value":31247.38,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":17423,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":499},"source":{"system":"sec-edgar","filing":"0001179110-17-000297","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911017000297/edgar.xml","form_type":"4"}},{"id":4563306,"issuer":{"id":1275,"kind":"organization","name":"3M CO","symbol":"MMM"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-11-09T21:45:55.000Z","date":"2016-11-08","kind":"grant","acquired":true,"shares":199,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non- Employee Directors."}],"balance_after":49346,"source":{"system":"sec-edgar","filing":"0001127602-16-066596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/66740/000112760216066596/form4.xml","form_type":"4"}},{"id":434566,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2016-10-05T20:50:48.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":313.14,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":18878.68,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":313.14},"source":{"system":"sec-edgar","filing":"0001225208-16-040199","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520816040199/doc4.xml","form_type":"4"}},{"id":434672,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-10-04T21:10:38.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":780,"price":42.29,"value":32986.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":19129,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":780},"source":{"system":"sec-edgar","filing":"0001179110-16-030316","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016030316/edgar.xml","form_type":"4"}},{"id":148337,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-10-04T17:45:23.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":495,"price":63.07,"value":31219.65,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":16772,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":495},"source":{"system":"sec-edgar","filing":"0001179110-16-030340","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911016030340/edgar.xml","form_type":"4"}},{"id":151088,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-07-15T19:49:48.000Z","date":"2016-06-30","kind":"grant","acquired":true,"shares":539,"price":61.91,"value":33369.49,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":16140,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":539},"source":{"system":"sec-edgar","filing":"0001179110-16-027684","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911016027684/edgar.xml","form_type":"4"}},{"id":436878,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2016-07-06T20:33:43.000Z","date":"2016-07-01","kind":"grant","acquired":true,"shares":317.92,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":18412.65,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":317.92},"source":{"system":"sec-edgar","filing":"0001225208-16-036336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520816036336/doc4.xml","form_type":"4"}},{"id":437007,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-07-05T21:11:48.000Z","date":"2016-06-30","kind":"grant","acquired":true,"shares":839,"price":39.31,"value":32981.09,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":18243,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":839},"source":{"system":"sec-edgar","filing":"0001179110-16-027360","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016027360/edgar.xml","form_type":"4"}},{"id":152920,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2016-05-10T17:23:55.000Z","date":"2016-05-06","kind":"grant","acquired":true,"shares":2974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":15581,"source":{"system":"sec-edgar","filing":"0001179110-16-024268","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911016024268/edgar.xml","form_type":"4"}},{"id":438812,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2016-05-03T21:24:37.000Z","date":"2016-04-29","kind":"grant","acquired":true,"shares":3799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":18345,"source":{"system":"sec-edgar","filing":"0001179110-16-023675","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016023675/edgar.xml","form_type":"4"}},{"id":439537,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2016-04-05T20:15:58.000Z","date":"2016-04-01","kind":"grant","acquired":true,"shares":327.12,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":17940.47,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":327.12},"source":{"system":"sec-edgar","filing":"0001225208-16-031047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520816031047/doc4.xml","form_type":"4"}},{"id":154120,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-04-04T17:18:18.000Z","date":"2016-03-31","kind":"grant","acquired":true,"shares":603,"price":57.12,"value":34443.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":15459,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":603},"source":{"system":"sec-edgar","filing":"0001179110-16-022683","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911016022683/edgar.xml","form_type":"4"}},{"id":439820,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-04-01T21:04:16.000Z","date":"2016-03-31","kind":"grant","acquired":true,"shares":788,"price":41.83,"value":32962.04,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":17286,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":788},"source":{"system":"sec-edgar","filing":"0001179110-16-022544","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016022544/edgar.xml","form_type":"4"}},{"id":443703,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2016-01-06T21:25:40.000Z","date":"2016-01-04","kind":"grant","acquired":true,"shares":293.46,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":17456.15,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":293.46},"source":{"system":"sec-edgar","filing":"0001225208-16-023773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520816023773/doc4.xml","form_type":"4"}},{"id":443855,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-01-05T22:06:43.000Z","date":"2015-12-31","kind":"grant","acquired":true,"shares":734,"price":44.91,"value":32963.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":16385,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":734},"source":{"system":"sec-edgar","filing":"0001179110-16-017083","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016017083/edgar.xml","form_type":"4"}},{"id":157951,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2016-01-05T17:12:56.000Z","date":"2015-12-31","kind":"grant","acquired":true,"shares":582,"price":59.24,"value":34477.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":14698,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":582},"source":{"system":"sec-edgar","filing":"0001179110-16-017099","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911016017099/edgar.xml","form_type":"4"}},{"id":445965,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2015-10-05T20:16:36.000Z","date":"2015-10-01","kind":"grant","acquired":true,"shares":316.37,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":17057.41,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":316.37},"source":{"system":"sec-edgar","filing":"0001225208-15-019224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520815019224/doc4.xml","form_type":"4"}},{"id":446115,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-10-02T21:07:52.000Z","date":"2015-09-30","kind":"grant","acquired":true,"shares":820,"price":40.22,"value":32980.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":15566,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":820},"source":{"system":"sec-edgar","filing":"0001179110-15-013724","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015013724/edgar.xml","form_type":"4"}},{"id":160929,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-10-02T16:48:12.000Z","date":"2015-09-30","kind":"grant","acquired":true,"shares":634,"price":54.41,"value":34495.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":13997,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":634},"source":{"system":"sec-edgar","filing":"0001179110-15-013704","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911015013704/edgar.xml","form_type":"4"}},{"id":449054,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2015-07-06T20:22:58.000Z","date":"2015-07-01","kind":"grant","acquired":true,"shares":293.43,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":16624.29,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":293.43},"source":{"system":"sec-edgar","filing":"0001225208-15-015200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520815015200/doc4.xml","form_type":"4"}},{"id":449171,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-07-02T21:04:13.000Z","date":"2015-06-30","kind":"grant","acquired":true,"shares":672,"price":49.08,"value":32981.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":14675,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":672},"source":{"system":"sec-edgar","filing":"0001179110-15-010818","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015010818/edgar.xml","form_type":"4"}},{"id":163017,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-07-02T16:56:10.000Z","date":"2015-06-30","kind":"grant","acquired":true,"shares":513,"price":67.19,"value":34468.47,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":13264,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":513},"source":{"system":"sec-edgar","filing":"0001179110-15-010802","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911015010802/edgar.xml","form_type":"4"}},{"id":164003,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.01 par value","published_at":"2015-05-12T17:52:30.000Z","date":"2015-05-08","kind":"grant","acquired":true,"shares":2187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":12607,"source":{"system":"sec-edgar","filing":"0001179110-15-007669","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911015007669/edgar.xml","form_type":"4"}},{"id":451671,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2015-04-28T21:11:46.000Z","date":"2015-04-24","kind":"grant","acquired":true,"shares":2793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":14546,"source":{"system":"sec-edgar","filing":"0001179110-15-006742","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015006742/edgar.xml","form_type":"4"}},{"id":452187,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2015-04-03T19:54:30.000Z","date":"2015-04-01","kind":"grant","acquired":true,"shares":277.93,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":16225.92,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":277.93},"source":{"system":"sec-edgar","filing":"0001225208-15-009492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520815009492/doc4.xml","form_type":"4"}},{"id":452345,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-04-02T21:04:21.000Z","date":"2015-03-31","kind":"grant","acquired":true,"shares":712,"price":46.33,"value":32986.96,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":13934,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":712},"source":{"system":"sec-edgar","filing":"0001179110-15-005831","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015005831/edgar.xml","form_type":"4"}},{"id":165254,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-04-02T17:24:10.000Z","date":"2015-03-31","kind":"grant","acquired":true,"shares":589,"price":58.54,"value":34480.06,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":12653,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":589},"source":{"system":"sec-edgar","filing":"0001179110-15-005864","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911015005864/edgar.xml","form_type":"4"}},{"id":457660,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2015-01-06T22:29:06.000Z","date":"2015-01-02","kind":"grant","acquired":true,"shares":316.18,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":15854.26,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":316.18},"source":{"system":"sec-edgar","filing":"0001225208-15-000872","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520815000872/doc4.xml","form_type":"4"}},{"id":457886,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-01-05T22:11:18.000Z","date":"2014-12-31","kind":"grant","acquired":true,"shares":733,"price":45.02,"value":32999.66,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":13153,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":733},"source":{"system":"sec-edgar","filing":"0001179110-15-000247","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015000247/edgar.xml","form_type":"4"}},{"id":168077,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2015-01-05T17:27:59.000Z","date":"2014-12-31","kind":"grant","acquired":true,"shares":527,"price":65.44,"value":34486.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":11963,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":527},"source":{"system":"sec-edgar","filing":"0001179110-15-000288","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911015000288/edgar.xml","form_type":"4"}},{"id":460843,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2014-10-03T20:33:29.000Z","date":"2014-10-01","kind":"grant","acquired":true,"shares":576.13,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":15452.67,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":576.13},"source":{"system":"sec-edgar","filing":"0001225208-14-021157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520814021157/doc4.xml","form_type":"4"}},{"id":169987,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2014-10-02T17:01:31.000Z","date":"2014-09-30","kind":"grant","acquired":true,"shares":597,"price":57.76,"value":34482.72,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie.  The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature."}],"balance_after":11361,"derivative":{"exercise_price":0,"underlying":"Common stock","underlying_shares":597},"source":{"system":"sec-edgar","filing":"0001179110-14-014929","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188983/000117911014014929/edgar.xml","form_type":"4"}},{"id":461146,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2014-10-01T21:10:09.000Z","date":"2014-09-30","kind":"grant","acquired":true,"shares":793,"price":41.59,"value":32980.87,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":12358,"derivative":{"exercise_price":0,"underlying":"Common shares","underlying_shares":793},"source":{"system":"sec-edgar","filing":"0001179110-14-014731","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911014014731/edgar.xml","form_type":"4"}},{"id":463488,"issuer":{"id":2862,"kind":"organization","name":"BOEING CO"},"owners":[{"id":11626,"kind":"person","name":"LIDDY EDWARD M","position":1,"cik":"0001188983","reported_name":"LIDDY EDWARD M","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2014-07-03T17:51:03.000Z","date":"2014-07-01","kind":"grant","acquired":true,"shares":567.09,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units are convertible into common stock on a 1-for-1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Phantom stock units awarded or acquired in lieu of director cash compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes adjustments for dividends accrued."}],"balance_after":14790.05,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":567.09},"source":{"system":"sec-edgar","filing":"0001225208-14-016495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12927/000122520814016495/doc4.xml","form_type":"4"}}],"next_cursor":"2014-07-03T17:51:03.000000Z,463488"}